Published in Transplantation on April 27, 2004
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res (2010) 2.21
Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04
Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol (2005) 2.00
Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) (2003) 1.70
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Polymorphonuclear elastase in the early diagnosis of complicated pyogenic pleural effusions. Respiration (2003) 1.42
Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg (2004) 1.35
The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol (2008) 1.11
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am J Ophthalmol (2002) 1.02
Predictive factors for early mortality following liver transplantation. Clin Transplant (2003) 1.01
Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transpl (2005) 0.99
Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg (2001) 0.98
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96
Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol (2008) 0.95
Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation (2007) 0.91
Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol (2005) 0.90
A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C. Transpl Int (2005) 0.89
Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol (2012) 0.88
Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci (2011) 0.87
Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet. Gut (2013) 0.87
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients. Int Immunopharmacol (2006) 0.85
Liver transplantation in infants weighing under 7 kilograms: management and outcome of PICU. Pediatr Transplant (2004) 0.84
Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy. Diabetes Care (2002) 0.84
Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg (2010) 0.84
Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transpl (2002) 0.83
Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Res Clin Pract (2005) 0.83
Psychosocial adjustment to orthotopic liver transplantation in 266 recipients. Liver Transpl (2004) 0.83
Our experience in liver transplantation in patients over 65 yr of age. Clin Transplant (2008) 0.83
FK506 in the maturation of dendritic cells. Haematologica (2002) 0.82
Aortic valve-derived calcifyng nanoparticles: no evidence of life. Rev Esp Cardiol (Engl Ed) (2012) 0.81
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther (2006) 0.81
Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure. Liver Int (2013) 0.79
Liver biopsy-related infection in liver transplant recipients: A current matter of concern? Liver Transpl (2014) 0.78
Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study. Clin Sci (Lond) (2003) 0.78
Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient. Transpl Int (2003) 0.78
[Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma]. Gastroenterol Hepatol (2008) 0.76
[Hepatic retransplantation]. Med Clin (Barc) (2005) 0.75
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues? Ann Hepatol (2011) 0.75
Analysis of growth during prepubertal years in long-term survivors after pediatric orthotopic liver transplantation. J Pediatr Endocrinol Metab (2004) 0.75
Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients. Liver Transpl (2011) 0.75
Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation. Transpl Int (2003) 0.75
[Hepatic angiomyolipoma in two patients infected with hepatitis C virus]. Gastroenterol Hepatol (2007) 0.75
Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study. Pediatr Transplant (2014) 0.75
Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study. Liver Transpl (2014) 0.75